Perioperative management of patients with cytoreductive surgery for peritoneal carcinomatosis.
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) has become an important tool in the management of patients with peritoneal malignancies. It is a complex surgical procedure with significant fluid loss during debulking leading to relevant pathophysiological alterations and therefore a challenge for anesthesiologists and critical care physicians. This review summarizes perioperative changes in hemodynamics, oxygen supply, coagulation, hematopoetic parameters and fluid status during cytoreductive surgery and HIPEC and how to deal with these pathophysiological alterations.
Schmidt
C
C
Department of Anesthesiology, University of Regensburg, Regensburg, Germany. christoph_schmidt2001@yahoo.de
Moritz
S
S
Rath
S
S
Grossmann
E
E
Wiesenack
C
C
Piso
P
P
Graf
B M
BM
Bucher
M
M
D001777:Blood Coagulation / Q000502:physiology; D006413:Hematopoietic System / Q000502:physiology; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D010101:Oxygen Consumption / Q000502:physiology; D019990:Perioperative Care / Q000379:methods*; D010534:Peritoneal Neoplasms / Q000503:physiopathology / Q000601:surgery*